Advances in Immunotherapy for Endometrial Cancer

Download the Podcast Pearls slideset with information on immunotherapy for endometrial cancer from Clinical Care Options.

This educational resource is intended for clinicians practicing medicine outside of the United States.

person default
Mansoor Raza Mirza, MD
Ana Oaknin, MD, PhD
Format: Microsoft PowerPoint (.ppt)
File Size: 1.19 MB
Released: November 12, 2020

Acknowledgements

Supported by an educational grant from
GlaxoSmithKline

Related Content

In this slideset from Clinical Care Options (CCO), experts provide insights on clinical trials of PARP inhibitor combinations in prostate cancer

Karim Fizazi, MD, PhD Joaquin Mateo, MD, PhD Released: April 19, 2021

In this slideset from Clinical Care Options (CCO), experts present the rationale for PARP inhibitor combination therapies in prostate cancer

Karim Fizazi, MD, PhD Joaquin Mateo, MD, PhD Released: April 16, 2021

Downloadable slideset reviewing the latest evidence on PARP inhibitor combinations in prostate cancer, from Clinical Care Options (CCO)

Charles J. Ryan, MD Released: April 12, 2021

Charles J. Ryan, MD, reviews PARP inhibitor combination therapy clinical trials in prostate cancer and the evidence supporting these approaches from Clinical Care Options (CCO)

Charles J. Ryan, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Released: April 12, 2021 Expired: April 11, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue